AI-generated summary
The authors studied low-level laser therapy (LLLT) in ovalbumin-induced allergic asthma in rats and compared it with the glucocorticoid budesonide. They report that LLLT at 8 J/cm2 once daily for 21 days reduced airway inflammation, lowered eosinophils and certain immune markers, and had an effect similar to budesonide. The study was conducted in rats, so the findings may not apply to humans.
- Who or what was studied
- Rats with ovalbumin-induced allergic asthma
- Limits stated in the abstract
- The study was conducted in rats, and the abstract does not report a human sample or a human trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.